Dr. Goodenowe presented recent clinical research results at a symposium at the 67th Annual Meeting of Japanese Society of Laboratory Medicine on November 22. He presented results from a study on 1,128 persons including 374 colorectal cancer subjects and 187 pancreatic cancer subjects as well as a 6-month study on plasmalogen supplementation with ProdromeNeuro in …
Unfortunately, a person can take all of the necessary preventative measures such as diet, exercise, and maintaining a healthy liver function, and still have a reduction in plasmalogen levels as they age. Although it is possible to have naturally high, protective levels of plasmalogens, only about 10 percent of people do. This is why incorporating …
Another important paper was published by independent researchers confirming Dr. Goodenowe’s (Founder and CEO, Prodrome Sciences) original discovery and hypothesis that plasmalogen deficiency is the key underlying causative factor in Alzheimer’s. In this new paper, researchers did a comprehensive comparison of blood biomarkers of Alzheimer’s in two large clinical trials – one from the USA and one …
Dr. Goodenowe is passionate about sharing his knowledge of biochemistry and health and disease. Get Certified for an in-depth course and invitation to Dr. Goodenowe’s monthly Physician Roundtable group. If you would like to offer Dr. Goodenowe’s blood testing and supplement products to your patients with flexible drop-ship options for you to grow your practice, please click here.
Dr. Goodenowe’s advanced lab testing and supplements are only available at Prodrome.com and through healthcare practitioners. Dr. Goodenowe is passionate about sharing what he has learned in his 30 years of research; join his free Educational Seminars for regular videos and presentations.
To better protect your privacy, we provide this notice explaining our online information practices and the choices you can make about the way your information is collected and used. To make this notice easy to find, we make it available on our homepage and at every point where personally identifiable information may be requested.
When visiting drdayangoodenowe.com, the IP address used to access the site will be logged along with the dates and times of access. This information is purely used to analyze trends, administer the site, track users’ movement and gather broad demographic information for internal use. Most important, any recorded IP addresses are not linked to personally identifiable information.
There are several ways to opt out of interest-based advertising and/or all tracking related to Google Analytics and its advertising features.
You can opt out of interest-based ads by Google through Ads Settings. When you opt out, you’ll still see ads but they may not be related to factors such as your interests, previous visits to other websites, or demographic details. Obtain instructions here.
The Network Advertising Initiative offers a free tool that allows users to opt out from receiving interest-based ads from some or all NAI participating member companies that use cookies on your computer browser to collect data for interest-based advertising. Find information about it here.
Website visitors can totally block Google Analytics with the Google Analytics opt-out browser add-on (click to download). This add-on instructs the Google Analytics JavaScript (ga.js, analytics.js, and dc.js) running on websites to prohibit their information from being used by Google Analytics. Using the Google Analytics opt-out plug-in will not prevent site owners from using other tools to measure site analytics. Learn more about about the opt-out and how to properly install the browser add-on here.
Statement The contents of this statement may be altered at any time, at our discretion.
If you have any questions regarding the privacy policy of drdayangoodenowe.com then you may contact us at info@drdayangoodenowe.com
